Related Experiment Video
Updated: Oct 22, 2025

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
[Danaparoid Sodium Controlled Chronic Disseminated Intravascular Coagulation Associated with Chronic Aortic
Okihiko Akashi1, Sadahiro Kanemura, Kensuke Kobayashi
1Department of Cardiovascular Surgery, Ikegami General Hospital, Tokyo, Japan.
Insights
Management of chronic disseminated intravascular coagulation (DIC) from aortic dissection is challenging. This case study shows danaparoid sodium effectively stabilized coagulative parameters and reduced bleeding in a patient with aortic dissection and a patent false lumen.
Area of Science:
- Cardiology
- Hematology
- Vascular Surgery
Background:
- Chronic disseminated intravascular coagulation (DIC) associated with aortic dissection lacks established management protocols.
- Aortic dissection, particularly with a patent false lumen, presents complex challenges in coagulation management.
Observation:
- A patient with chronic DIC secondary to aortic dissection experienced an acute exacerbation.
- The patient had a patent false lumen, complicating the DIC management.
Findings:
- Treatment with danaparoid sodium (2,000 U/day) successfully stabilized both coagulative and fibrinolytic parameters.
- Danaparoid sodium effectively relieved bleeding tendencies without any observed side effects during long-term administration.
Implications:
- This case suggests danaparoid sodium may be a viable therapeutic option for managing acute exacerbations of chronic DIC in aortic dissection patients.
- Further research is warranted to explore the efficacy and safety of danaparoid sodium in similar complex cardiovascular and hematological conditions.
Abstract:
The management of chronic disseminated intravascular coagulation( DIC) caused by aortic dissection has not yet been established. We report the successful treatment of a case of aortic dissection with a patent false lumen using danaparoid sodium for acute exacerbation of chronic DIC. 2,000 U danaparoid sodium per day has been stabilizing the coagulative and fibrinolytic parameters and has been relieving bleeding tendencies with no side effects for a long term.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management

